Three Approaches to NAD+ Restoration
NAD+ (nicotinamide adenine dinucleotide) research has expanded to include not just direct NAD+ supplementation but also its precursors NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Each form has distinct pharmacological properties that influence research design.
The NAD+ Biosynthesis Pathway
Understanding the relationship requires knowing the biosynthesis pathway: NR ? NMN ? NAD+. NR is phosphorylated by NRK enzymes to form NMN, which is then converted to NAD+ by NMNAT enzymes. Direct NAD+ supplementation bypasses both conversion steps.
Comparison
| Feature | NAD+ | NMN | NR |
|---|---|---|---|
| Molecular weight | 663 Da | 334 Da | 255 Da |
| Oral bioavailability | Very low | Moderate (debated) | Good |
| Preferred route | IV or subcutaneous | Oral or SC | Oral |
| Conversion steps to NAD+ | 0 (direct) | 1 step | 2 steps |
| Cellular uptake | Limited (large molecule) | Via Slc12a8 transporter | Via ENTs |
| Price point | Highest | Moderate | Lowest |
Direct NAD+
Direct NAD+ supplementation provides immediate bioavailability without requiring enzymatic conversion. However, its large molecular size limits oral absorption, making injectable (IV or subcutaneous) administration the primary route. IV NAD+ produces rapid, measurable increases in intracellular NAD+ levels. See our NAD+ dosage guide.
NMN
NMN is one enzymatic step away from NAD+ and has demonstrated oral bioavailability in recent research, particularly with the discovery of the Slc12a8 transporter in the gut. NMN studies have shown improvements in various metabolic parameters and represent a middle ground between direct NAD+ and NR.
NR (Nicotinamide Riboside)
NR has the best oral bioavailability of the three and the most extensive human clinical trial data (multiple Phase 2 trials). However, it requires two enzymatic conversion steps to become NAD+, and conversion efficiency varies between tissues.
Which to Choose for Research?
Direct NAD+: When immediate, maximal NAD+ elevation is needed and injectable administration is acceptable. NMN: When oral administration is preferred with fewer conversion steps. NR: When oral bioavailability and clinical evidence are priorities.
For research purposes only. Visit COAs and catalog.